Skip to main content

Deciphera Pharmaceuticals, Inc.

DCPHDelisted Jun 11, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001654151

Deciphera Pharmaceuticals, Inc. was delisted on Jun 11, 2024; its insiders filed their last Form 4 on Jun 11, 2024; 177 institutions reported holding it in 13F filings for Q1 2024, worth $943.7M in total; no superinvestor held it.

Q1 2022 vs. Q4 2021

How the institutions holding Deciphera Pharmaceuticals, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of DCPH: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders140123−17
Shares45.9M43.6M−2.33M (−5.1%)
Value$452.1M$403.2M−$48.9M (−10.8%)

New holders (18)

Institutions that held Deciphera Pharmaceuticals, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to DCPH in Q1 2022
InstitutionSharesValue% of portfolio
Laurion Capital Management LP459,290$4.26M0.10%
ExodusPoint Capital Management, LP277,155$2.57M0.04%
HRT Financial LP242,998$2.25M0.02%
PDT Partners, LLC222,343$2.06M0.18%
Pinz Capital Management, LP165,835$1.54M0.96%
Hudson Bay Capital Management LP55,000$510.0K0.01%
Tudor Investment Corp Et Al49,084$455.0K0.01%
Bayesian Capital Management, LP41,900$388.0K0.06%
Healthcare of Ontario Pension Plan Trust Fund30,000$278.0K0.00%
Franklin Resources Inc13,317$123.0K0.00%
Los Angeles Capital Management LLC10,580$98.0K0.00%
Amalgamated Bank6,196$57.0K0.00%
Lazard Asset Management LLC6,182$57.0K0.00%
Amalgamated Financial Corp.6,196$57.0K0.00%
Walleye Trading LLC781$7.00K0.00%
Capital Advisors, Ltd. LLC66$1.00K0.00%
Glassman Wealth Services62$1.00K0.00%
Lindbrook Capital, LLC142$1.00K0.00%

Sold out (35)

Institutions that held Deciphera Pharmaceuticals, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.